() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: NSHS

NanoSphere Opens $2 million Private Placement Offering

Feb 13/2019 NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“Nanosphere” or “the Company”) is pleased to announce that it will conclude a private placement of up to CAD$2,000,000, which will incorporate the balance of the financing announced on November 16, 2018 as updated December 17, 2018.
Read more

Game-Changing NanoSphere Products Soon to Disrupt the Oklahoma Cannabis Market

NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today signed a new letter of intent with 4Evergrn LLC, which will bring Evolve Formulas products to the Oklahoma medical and recreational cannabis markets. The brand’s pioneering product, the Evolve Formulas Transdermal NanoSerum™, will hit dispensary shelves in the third quarter of 2019.
Read more

Delta 9 Signs Master License Agreement with NanoSphere Health Sciences

Jan. 24, 2019 /CNW/ - DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the "Company") is pleased to announce it has signed a Master License Agreement (the "Agreement") with NanoSphere Health Sciences, LLC ("NSHS") and its Canadian subsidiary, NanoSphere Cannabis International Inc. ("NCI", and collectively with NSHS, "NanoSphere").
Read more